We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial.
- Authors
Mok, C C; Tong, K H; To, C H; Siu, Y P; Ma, K M
- Abstract
This 6-month randomized double-blind placebo-controlled trial shows that risedronate is well tolerated and effective in improving lumbar spine BMD and reducing loss of BMD at the hips in patients receiving high-dose prednisolone.
- Publication
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Vol 19, Issue 3, p357
- ISSN
0937-941X
- Publication type
Journal Article
- DOI
10.1007/s00198-007-0505-y